Anavex Life Sciences AVXL
NASDAQ AVXL
$2.02 -0.34 (-14.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Assets (2011 - 2026)

Updated

Anavex Life Sciences (AVXL) posted Assets of $120.14 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 17.3% from $102.43 million a year earlier but down 6.7% from the prior quarter.

Analysis

Anavex Life Sciences (AVXL) Assets (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Assets came in at $103.82 million, down 23.4% from FY2024.

  • Annual Assets shows a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
  • In prior fiscal years, Anavex Life Sciences' Assets was $135.57 million in FY2024 (-12.2%), $154.39 million in FY2023 (+1.1%), $152.71 million in FY2022 (-5.5%) and $161.62 million in FY2021 (+367.9%).
  • Quarterly Assets has run from a low of $102.43 million in fiscal Q3 2025 to a high of $161.62 million in fiscal Q4 2021 over five years.
  • On a year-over-year basis, Assets has increased in each of the last three quarters, with an average decline of 8.0% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was fiscal Q4 2021, with growth of 367.9%; the weakest was fiscal Q3 2025, with a decline of 27.6%.
  • According to Business Quant data, Assets for the three prior fiscal quarters was $128.77 million (Q2 2026), $132.99 million (Q1 2026) and $103.82 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Anavex Life Sciences 187.25 Mn -292.83 Mn - 120.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.14 Mn
Mar 31, 2026 128.77 Mn
Dec 31, 2025 132.99 Mn
Sep 30, 2025 103.82 Mn
Jun 30, 2025 102.43 Mn
Mar 31, 2025 117.14 Mn
Dec 31, 2024 124.04 Mn
Sep 30, 2024 135.57 Mn
Jun 30, 2024 141.54 Mn
Mar 31, 2024 144.52 Mn
Dec 31, 2023 148.07 Mn
Sep 30, 2023 154.39 Mn
Jun 30, 2023 157.81 Mn
Mar 31, 2023 159.19 Mn
Dec 31, 2022 148.37 Mn
Sep 30, 2022 152.71 Mn
Jun 30, 2022 160.22 Mn
Mar 31, 2022 160.28 Mn
Dec 31, 2021 156.90 Mn
Sep 30, 2021 161.62 Mn
API Access

Anavex Life Sciences Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=AVXL&period=max&api_key=YOUR_API_KEY